Continued decline in blood collection and transfusion in the United States-2015

Katherine D Ellingson1,2, Mathew R P Sapiano1,3, Kathryn A Haass1

  • 1Office of Blood, Organ, and Other Tissue Safety, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Transfusion
|June 8, 2017
PubMed

Insights

Blood collection and transfusion in the U.S. continued to decline in 2015, according to the National Blood Collection and Utilization Survey (NBCUS). This trend highlights the need for ongoing monitoring of blood services to ensure adequate inventory.

Area of Science:

  • Blood Services
  • Transfusion Medicine
  • Public Health Surveillance

Background:

  • Previous National Blood Collection and Utilization Surveys (NBCUS) in 2011 and 2013 indicated decreasing trends in blood collection and transfusion rates within the United States.
  • Understanding the current state of blood services is crucial for public health preparedness and resource management.

Purpose of the Study:

  • To comprehensively describe the status of blood collection, distribution, transfusion, and pricing in the United States for the year 2015.
  • To identify trends in blood product utilization and inventory management.

Main Methods:

  • The 2015 National Blood Collection and Utilization Survey (NBCUS) was administered to a comprehensive sample of U.S. blood collection centers and hospitals.
  • Data collection included units of blood and components collected, deferred, distributed, transfused, and outdated, with weighting and imputation used for national estimates.

Main Results:

  • In 2015, 12,591,000 units of red blood cells (RBCs) were collected and 11,349,000 were transfused, marking significant declines from 2013 levels.
  • Total platelet and plasma units distributed and transfused also showed decreases compared to 2013.
  • Median prices for leukocyte-reduced RBCs, apheresis platelets, and fresh frozen plasma were lower in 2015 than in 2013.

Conclusions:

  • The findings indicate a continued reduction in demand for blood products, leading to decreased collection and distribution.
  • Sustaining an adequate blood supply for both routine and emergency needs necessitates continuous monitoring and a deeper understanding of these evolving trends.
  • The study underscores the dynamic nature of blood services and the importance of adaptive strategies.
Abstract

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.1K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.6K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
3.7K